Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 18, 2018
Pharmacovigilance Evaluation of the Association Between DPP-4 Inhibitors and Heart Failure: Stimulated Reporting and Moderation by Drug Interactions
Gian Paolo Fadini, Mayur Sarangdhar, Angelo Avogaro
BMJ Open Diabetes Research & Care
|
February 17, 2018
Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System
Gian Paolo Fadini, Mayur Sarangdhar, Angelo Avogaro
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science
|
December 5, 2013
Using Systems Biology-based Analysis Approaches to Identify Mechanistically Significant Adverse Drug Reactions: Pulmonary Complications from Combined Use of Anti-TNFα Agents and Corticosteroids
Mayur Sarangdhar, Akash Kushwaha, Jeanine Dahlquist, et al.
BMJ Open Diabetes Research & Care
|
October 24, 2019
Pharmacovigilance assessment of the association between Fournier's gangrene and other severe genital adverse events with SGLT-2 inhibitors
Gian Paolo Fadini, Mayur Sarangdhar, Fabrizio De Ponti, et al.
The Journal of Antimicrobial Chemotherapy
|
March 11, 2026
Prioritization of adverse events related to integrase inhibitors and NNRTIs: a disproportionality analysis using data from the FAERS database
Gao-Yang Wang, Shuang Xia, Mayur Sarangdhar, et al.
Journal of Personalized Medicine
|
July 2, 2021
The Impact of Marijuana on Antidepressant Treatment in Adolescents: Clinical and Pharmacologic Considerations
Samuel E Vaughn, Jeffrey R Strawn, Ethan A Poweleit, et al.
Frontiers in Pharmacology
|
September 24, 2024
Tumor lysis syndrome signal with the combination of encorafenib and binimetinib for malignant melanoma: a pharmacovigilance study using data from the FAERS database
Shuang Xia, Jing-Wen Xu, Kang-Xin Yan, et al.
Cancers
|
January 8, 2023
Association of Pulmonary Sepsis and Immune Checkpoint Inhibitors: A Pharmacovigilance Study
Shuang Xia, Hui Gong, Yichang Zhao, et al.
Frontiers in Pharmacology
|
February 9, 2024
Disproportional signal of pericarditis with biological diseasemodifying antirheumatic drugs (bDMARDs) in patients with ankylosing spondylitis: a disproportionality analysis in the FAERS database
Shuang Xia, Yun-Fei Li, Emanuel Raschi, et al.
Clinical Pharmacology and Therapeutics
|
April 22, 2023
Tumor Lysis Syndrome Associated with Monoclonal Antibodies in Patients with Multiple Myeloma: A Pharmacovigilance Study Based on the FAERS Database
Shuang Xia, Hui Gong, Yichang Zhao, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 18, 2018
Pharmacovigilance Evaluation of the Association Between DPP-4 Inhibitors and Heart Failure: Stimulated Reporting and Moderation by Drug Interactions
Gian Paolo Fadini, Mayur Sarangdhar, Angelo Avogaro
BMJ Open Diabetes Research & Care
|
February 17, 2018
Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System
Gian Paolo Fadini, Mayur Sarangdhar, Angelo Avogaro
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science
|
December 5, 2013
Using Systems Biology-based Analysis Approaches to Identify Mechanistically Significant Adverse Drug Reactions: Pulmonary Complications from Combined Use of Anti-TNFα Agents and Corticosteroids
Mayur Sarangdhar, Akash Kushwaha, Jeanine Dahlquist, et al.
BMJ Open Diabetes Research & Care
|
October 24, 2019
Pharmacovigilance assessment of the association between Fournier's gangrene and other severe genital adverse events with SGLT-2 inhibitors
Gian Paolo Fadini, Mayur Sarangdhar, Fabrizio De Ponti, et al.
The Journal of Antimicrobial Chemotherapy
|
March 11, 2026
Prioritization of adverse events related to integrase inhibitors and NNRTIs: a disproportionality analysis using data from the FAERS database
Gao-Yang Wang, Shuang Xia, Mayur Sarangdhar, et al.
Journal of Personalized Medicine
|
July 2, 2021
The Impact of Marijuana on Antidepressant Treatment in Adolescents: Clinical and Pharmacologic Considerations
Samuel E Vaughn, Jeffrey R Strawn, Ethan A Poweleit, et al.
Frontiers in Pharmacology
|
September 24, 2024
Tumor lysis syndrome signal with the combination of encorafenib and binimetinib for malignant melanoma: a pharmacovigilance study using data from the FAERS database
Shuang Xia, Jing-Wen Xu, Kang-Xin Yan, et al.
Cancers
|
January 8, 2023
Association of Pulmonary Sepsis and Immune Checkpoint Inhibitors: A Pharmacovigilance Study
Shuang Xia, Hui Gong, Yichang Zhao, et al.
Frontiers in Pharmacology
|
February 9, 2024
Disproportional signal of pericarditis with biological diseasemodifying antirheumatic drugs (bDMARDs) in patients with ankylosing spondylitis: a disproportionality analysis in the FAERS database
Shuang Xia, Yun-Fei Li, Emanuel Raschi, et al.
Clinical Pharmacology and Therapeutics
|
April 22, 2023
Tumor Lysis Syndrome Associated with Monoclonal Antibodies in Patients with Multiple Myeloma: A Pharmacovigilance Study Based on the FAERS Database
Shuang Xia, Hui Gong, Yichang Zhao, et al.
Page
of 2